Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Baricitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 21,499Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Olumiant

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Olumiant

    Baricitinib

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Olumiant

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Baricitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 639

    2019 Revenue in Millions : 427

    Growth (%) : 50

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Olumiant

    Baricitinib

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Olumiant

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Baricitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 1,115

    2020 Revenue in Millions : 639

    Growth (%) : 75

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Olumiant

    Baricitinib

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Olumiant

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Baricitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 831

    2021 Revenue in Millions : 1,115

    Growth (%) : -26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Olumiant

    Baricitinib

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Olumiant

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Baricitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 923

    2022 Revenue in Millions : 831

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Olumiant

    Baricitinib

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Olumiant

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Baricitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2019 Revenue in Millions : 427

    2018 Revenue in Millions : 203

    Growth (%) : 111

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF